Bill
Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021
passed, as at 2021-06-24. Health portfolio.
- Sponsor
- Not recorded
- Portfolio
- Health
Recorded stages
- introduced — 2021-02-03
- second reading — 2021-02-03
- second reading — 2021-02-24
- second reading — 2021-02-24
- third reading — 2021-02-24
- introduced — 2021-02-25
- second reading — 2021-02-25
- second reading — 2021-06-17
- second reading — 2021-06-17
- third reading — 2021-06-17
- passed — 2021-06-17
- royal assent — 2021-06-24
Divisions
No divisions recorded. Most questions are decided on the voices; this does not establish that a bill was unopposed.
Plain-language summary
Written by a model from the explanatory memorandum; not the record, as at 2021-02-03.
The bill would simplify the licensing system for medicinal cannabis by merging three existing licences into one.
It would introduce a perpetual licence with periodic permits for most activities, replacing the current structure to reduce regulatory burden.
The bill implements recommendations from the 2019 McMillan Review and also creates two new strict liability offences for manufacturing without authorisation and breaching a licence condition.
- Consolidates the three-licence structure into a single licence.
- Introduces a perpetual licence and periodic permit framework.
- Creates strict liability offences for unauthorised manufacture and licence condition breaches.
Industry participants involved in cultivating, producing, manufacturing, or researching medicinal cannabis.
Sources
em
billhome
frl act